Sarissa Biomedical is developing a range of minimally invasive, microelectrode electrochemical sensors for the measurement of the purines and other neurochemicals, as indicators of neurological activity/disorders.
Mercia Growth EIS Fund - £10m opportunity offering a series of tax benefits including up to 30% income tax relief, CGT deferral and inheritance tax exemption.
Last chance to receive an Early Bird incentive!
Click here for further information.
Quick Contact